Significant Ownership of Daewoong Co., Ltd
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Daewoong Co., Ltd focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Bumseok Kim - Bumseok Kim/Authorized Signatory
- Manager location
- Seongnam Si, Gyeonggi Do, Korea, Republic of
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
CIK context first
Continue from Daewoong Co., Ltd
Significant Ownership of Daewoong Co., Ltd
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AEON Biopharma, Inc. | Common Stock, $0.0001 par value per share | 50% | 12,009,737 | +13046% | Daewoong Co.,Ltd. ("DWC") | 21 Jan 2026 | |||
| AEON | AEON Biopharma, Inc. | Class A Common Stock, $0.0001 par value per share | 31% | $5,345,786 | 23,242,546 | Daewoong Co., Ltd. | 30 Oct 2026 |
Schedules 13D/G Reported by Daewoong Co., Ltd:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.